Inicure AB
PrivateLast Round
Grant
Jun 3, 2026
Total Funding Raised
$40,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Inicure AB is a biotechnology company that develops small-molecule formyl peptide receptor-1 (FPR1) agonists to treat infectious diseases and combat antibiotic resistance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inicure AB Comparables
Compare Inicure AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| smartbax GmbH | 84% | |
| Disperazol Pharma ApS | 82% | |
| APY Therapeutics | 79% |
Inicure AB Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 3, 2026 | ||||
| Grant | Feb 13, 2026 | ||||
| Accelerator | Jun 1, 2024 |
Inicure AB Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vasa Angels I | Accelerator |
| INCATE | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 3, 2026
Secured $30K in grant funding.
- Feb 13, 2026
$10K grant received.
Inicure AB Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Inicure AB's valuation, stock price, and market status.
Is Inicure AB a public or private company?
Inicure AB is a private company.
What is the current stock price of Inicure AB?
Inicure AB is a private company with no public stock price. Caplight tracks Inicure AB's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Inicure AB worth (valuation)?
Valuation information for Inicure AB is not publicly available.
Can I buy Inicure AB stock?
Inicure AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Inicure AB's last funding round?
Inicure AB's most recent funding round was Grant on June 3, 2026.
Who are the main investors in Inicure AB?
Key investors in Inicure AB include Vasa Angels I.
Will Inicure AB IPO soon?
No public IPO plans have been announced for Inicure AB.
How can I track Inicure AB secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Inicure AB's secondary market activity and sign up for updates.